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Abstract
Ventilator associated pneumonia (VAP) is a common nosocomial infection that results in
both negative patient outcomes and increased healthcare costs. Recently many efforts
have been targeted at VAP prevention including the practice of subglottic secretion
aspiration. Six randomized control studies examining the effectiveness of subglottic
secretion aspiration in the prevention of ventilator-associated pneumonia were reviewed.
Results consistently show that subglottic secretion aspiration significantly reduces the
incidence of VAP in a variety of patient populations. Despite these findings, this practice
is limited in clinical settings. This clinical practice should be implemented in individuals
requiring mechanical ventilation in order to reduce the incidence of ventilator-associated
pneumonia.

Ventilator associated pneumonia (VAP) is a common nosocomial infection that
results in both negative patient outcomes and increased healthcare costs. VAP is the
most commonly diagnosed nosocomial infection among mechanically ventilated patients
affecting 10-20 % of this specific patient population.1
A recent systematic review found that patients who acquired VAP spent an
additional five to seven days requiring care in the intensive care unit (ICU) and had a 15
to 50 percent higher mortality rate when compared with those who did not develop VAP.
In addition, the diagnosis of VAP was associated with increased health care cost ranging
from $10,000 to $13,000 per case. Costs associated with VAP have been predicted to
accrue to 1.5 billion health care dollars annually.1
In the past decade, large-scale initiatives have been employed by healthcare
workers to target VAP prevention. Of recent interest is the role of subglottic secretions in
the pathogenesis of nosocomial pneumonia. Studies have confirmed that bacteria that
pools above the endotracheal cuff provides a mechanism for bacterial proliferation. The
translocation of these secretions past the endotracheal tube cuff and into the lung
parenchyma contributes to the development of VAP.2
In 1992, the Hi Lo Evac tube was developed by Nellcor Puritan Bennett
Incorporated in order to provide a mechanism to remove subglottic secretions.3 This
specialized endotracheal tube contains an additional lumen that terminates above the
tracheal cuff and connects to an external suctioning port, allowing the removal of
secretions from the subglottic region. Although intended for continuous suction,
subglottic secretion evacuation can be achieved through various methods including
continuous, intermittent, or manual aspiration.

Since it’s introduction into the medical community, many studies have examined
the efficacy and effectiveness of subglottic secretion aspiration. The purpose of this
review is to assess the impact of subglottic secretion aspiration on the prevalence of VAP
and to examine the implications of this technology in the context of current medical
practice.
METHODS
Study Selection
The University of Pennsylvania’s Ovid interface was used to produce relevant
articles. Specifically MEDLINE, CINAHL and the Cochrane library databases were
searched. Keywords used in the search included subglottic suctioning, subglottic
drainage, and subglottic secretion. Studies were limited to randomized clinical trials that
were printed in English and published between January 1992 and November 2008.
Studies were further limited to those that included clinical outcome measurements.
Data Synthesis
The primary outcome of interest was prevalence of VAP. Secondary outcome
measurements varied by study. Common shared endpoints included ICU and hospital
lengths of stay, mortality rate, length of time requiring mechanical ventilation and time
until VAP diagnosis. Studies were examined based on sample, treatment variable,
outcome measures, findings, and comments (Table 1).
Results
After the initial search query a total of fifteen studies were identified. From these
findings, six studies 4, 5, 6. 7, 8, and 9 met the inclusion criteria. Three studies were excluded
for not being published in English, two studies were excluded for examining alternative

endpoints, and four studies were excluded for not using subglottic secretion drainage as
the experimental variable.
Participants
A total of 1848 patients were studied in the six clinical trials. All participants
required mechanical ventilation. Patient populations varied by study and included
patients with a wide variety of medical conditions. Reasons for mechanical intubation
included post-surgical management, acute respiratory failure, shock, cardiac failure,
community-acquired pneumonia, neurological disease and trauma.
Treatment
The treatment group in each trial received some form of subglottic secretion
aspiration. However, the specific mechanism varied between studies including
continuous, intermittent, or manual evacuation of subglottic secretions. The studies
outlined in detail the exact protocol used for subglottic secretion aspiration (Table 1).
Control groups received standard endotracheal tube (ETT) care without subglottic
suctioning. Additional variables included randomization of various types of
gastrointestinal prophylaxis in one study 4, and the concurrent use of a polyurethane cuff
in another study 5. Each study specified the process in which randomization was ensured.
Findings
Participants of each study were found to have similar demographic findings
between the control and treatment groups. No significant statistical difference was
demonstrated between age, gender, comorbidities, reason warranting mechanical
ventilation, Acute Physiology and Chronic Health Evaluation (APACHE) II or Simplified
Acute Physiology (SAP) scores. Of note one study found a disproportionate amount of

patients who received a specific type of cardiovascular surgery in the control group
versus the treatment group 9, however, this variable was not thought to affect the study
results.
Although the findings varied by study, the percentage of patients in the treatment
group who developed VAP was lower than the percentage of patients who developed
VAP in the control groups, in all six studies. In addition, four out of the six studies found
that patients who received subglottic secretion aspiration had a later onset of VAP
diagnosis. [4], [5], [6] and [8] No adverse events due to subglottic secretion aspiration were
reported. Mixed statistically significant findings were reported in the addition secondary
endpoints.
Implications for Clinical Practice
Aspiration of subglottic secretions has been widely accepted by recommending
agencies and has been incorporated in VAP prevention guidelines. Currently the
American Thoracic Society recommends the use of continuous aspiration of subglottic
secretions to combat VAP as a Level I recommendation, the highest level of evidence in
their grading system.10 In addition, the American Association of Critical Care Nurses
recommends that subglottic secretion aspiration be incorporated into standard nursing
care 11.
Despite research confirming the benefits of subglottic secretion aspiration in VAP
prevention, significant obstacles have prevented the dissemination of this practice into
routine patient care. One study found that nurses performed subglottic secretion
aspiration a mere 17.6 % of the time.12 Reasons for failure to provide subglottic
suctioning included lack of availability of equipment and perception that subglottic

suctioning may cause either patient discomfort or adverse side effects. A small
percentage of nurses reported refrain from enforcing VAP guidelines due to disagreement
with clinical trial results.
In lieu of the increase in knowledge about ventilator associated pneumonia
prevention strategies, this nosocomial infection still affects a large number of patients in
intensive care units throughout the country. Nurses and other healthcare workers have an
important role in the promotion of VAP prevention including implementing a unit-based
protocol for the practice of subglottic secretion aspiration. Moreover endotracheal tubes
that are equipped to provide subglottic secretion aspiration should be readily available in
areas where intubation occurs frequently including emergency departments, operating
rooms, intensive care units, and pre-hospital settings.
Discussion
Subglottic secretion aspiration has been widely studied by randomized control
trials in a large variety of patient populations including both medical and surgical
patients. Findings have shown that this simple technology is effective in preventing the
development of ventilator-associated pneumonia. Of the 1848 patients studied, no
adverse events associated with subglottic secretion aspiration were reported. In addition,
findings have consistently shown that patients who receive subglottic secretion aspiration
have a delayed onset of nosocomial pneumonia. This finding demonstrates an added
benefit in patients who may require mechanical ventilation for a shorter period of time.
In conclusion, subglottic secretion aspiration is both a safe and effective therapy.
It should be implemented in individuals requiring mechanical ventilation in order to

reduce the incidence of ventilator-associated pneumonia in this vulnerable patient
population.
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